
US Stock Market Nosedives as First Omicron Case Was Reported in California
While pharmaceutical outfits will be looking at modifying existing COVID-19 vaccine formulas to combat Omicron, the ensuing lockdown is an indication that the world is bound to have a long ride with this new coronavirus variant.